LIFR antibody (AA 915-1086)
Quick Overview for LIFR antibody (AA 915-1086) (ABIN7158226)
Target
See all LIFR AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 915-1086
-
Cross-Reactivity
- Human, Rat
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Leukemia inhibitory factor receptor protein (915-1086AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: WB:1:500-1:5000, IHC:1:500-1:1000, IF:1:200-1:500,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LIFR (Leukemia Inhibitory Factor Receptor alpha (LIFR))
-
Alternative Name
- LIFR
-
Background
-
Background: Signal-transducing molecule. May have a common pathway with IL6ST. The soluble form inhibits the biological activity of LIF by blocking its binding to receptors on target cells.
Aliases: CD118 antibody, CD118 antigen antibody, FLJ98106 antibody, FLJ99923 antibody, Leukemia inhibitory factor receptor alpha antibody, Leukemia inhibitory factor receptor antibody, LIF R antibody, LIF receptor antibody, LIF-R antibody, Lifr antibody, LIFR_HUMAN antibody, SJS2 antibody, STWS antibody, SWS antibody
-
UniProt
- P42702
-
Pathways
- JAK-STAT Signaling, Growth Factor Binding
Target
-